Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Divestments (2017 - 2019)

Healthstream (HSTM) has disclosed Divestments for 3 consecutive years, with $35000.0 as the latest value for Q4 2019.

  • On a quarterly basis, Divestments rose 100.25% to $35000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was -$13.9 million, a 131.63% decrease, with the full-year FY2019 number at $6.1 million, down 86.22% from a year prior.
  • Divestments was $35000.0 for Q4 2019 at Healthstream, up from -$187000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $58.2 million in Q1 2018 to a low of -$13.8 million in Q4 2018.
  • A 3-year average of $4.1 million and a median of -$459500.0 in 2017 define the central range for Divestments.
  • Peak YoY movement for Divestments: skyrocketed 9237.05% in 2018, then plummeted 18600.0% in 2019.
  • Healthstream's Divestments stood at -$544000.0 in 2017, then plummeted by 2432.72% to -$13.8 million in 2018, then skyrocketed by 100.25% to $35000.0 in 2019.
  • Per Business Quant, the three most recent readings for HSTM's Divestments are $35000.0 (Q4 2019), -$187000.0 (Q3 2019), and -$13.8 million (Q4 2018).